Purpose. Science.
Impact.

Empower organisations to deploy AI that is scalable, privacy-preserving, and sovereign — unlocking innovation without compromising data control or compliance.

To lead the future of AI through ATD, enabling decentralised and centralised intelligence that is secure, efficient, and scalable across global industries.

BMed (Hons) FRCS Ed FRACDS(OMS) GAICD

Dr Anthony Lynham is a well-respected Maxillofacial Surgeon with extensive experience in research and administration. He has held significant leadership positions in medicine, research and more broadly in the community.

He is a Fellow of the Royal College of Surgeons, an Associate Professor of The University of Queensland School of Medicine, and an Adjunct Professor of the Queensland University of Technology. He serves on several government and commercial boards.

Dr Leech has over twenty years' experience developing technology in the biotech industry, commercialising animal health, aquaculture, agriculture, medical device, and human therapeutic products.

He completed his postdoctoral studies at Virginia Commonwealth University, and holds a PhD in Biochemistry from the University of Queensland.

He completed his legal studies through the University of Technology Sydney and is registered as a patent and trademark attorney. Dr Leech currently sits on the board of several biotechnology companies.

CA, FTIA, FSSA, B.Ec (Acc), Grad Dip (Fin Planning) FBA AM

Carolyn is founder and Chair of boutique accounting firm CJBA Advisory, established after leaving Ernst & Young Business Transition Tax and Superannuation Services.

With experience in Audit and Financial Services at PricewaterhouseCoopers, specialising in Data and Governance nationally, she performed financial strategy advisory for several international and high-profile Australian companies.

Carolyn's contributions extend to national papers, journals, public speaking engagements, and educational forums.

Michael Finney is a successful lawyer and experienced senior executive with over 25 years' experience in the intellectual property, commercialisation, and technology sectors.

He has a strong technical background in engineering, ICT, and biomedical technology disciplines and is a Fellow of the Australian Institute of Company Directors.

Michael delivers innovative business solutions and creative outcomes in managing risk and leveraging commercial value across complex technology ventures.